Last month, India and South Africa led several countries in calling for patents and other intellectual properties related to COVID-19 to be waived during the pandemic. While the movement has gained traction through recent talks, many notable countries have said “no”. So is such a waiver necessary or important to better tackle the pandemic?

Image Source: Shutterstock 

Produced by: Lim Sue Ann

Presented by: Juliet Jacobs, Lim Sue Ann, Dashran Yohan

This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories:  Health Policy,  Diseases and Conditions,  Mental Health,  Healthy Living,  Fitness,  Science,  Politics,  Social Issues,  Medical Innovation and Technology

Tags:  The Bigger Picture,  The Daily Digest,  COVID-19,  Vaccine,  Intellectual Property,  Patent,  Waiver,  World Trade Organisation,  World Intellectual Property Organisation (WIPO),  Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement),  COVAX,  Médecins Sans Frontières,  Doctors Without Borders,  Pharmaceutical Companies,